Show simple item record

dc.contributor.authorCamp, D
dc.date.accessioned2017-05-03T11:30:49Z
dc.date.available2017-05-03T11:30:49Z
dc.date.issued2013
dc.date.modified2014-01-08T04:59:46Z
dc.identifier.issn0377-8282
dc.identifier.urihttp://hdl.handle.net/10072/55342
dc.description.abstractThe landscape of small-molecule drug discovery has undergone substantial changes over the past 20 years, in which the testing of tens to hundreds of compounds in animal models was replaced by the high-throughput screening (HTS) of megalibraries against modified cell lines or isolated biomolecular targets. Natural products were a fruitful source of lead molecules, but their impact waned considerably since their heyday between the 1940s and 1960s. During the 1990s, pharmaceutical companies began to invest heavily in the HTS of combinatorial chemistry libraries that typically contained compounds with non-natural (synthetic) motifs. Incredibly, the contribution by natural products towards lead molecules (chemical starting points) and drugs remained steady despite the diversion of resources and the general decline in discovery. An analysis covering the 30-year period to December 2010 indicated that approximately 39% of all 1,068 small-molecule new chemical entities were either a natural compound, close semi-synthetic analogue or a synthetic analogue of the natural product pharmacophore. The application of concepts, methodologies and knowledge learned during maturation of the high-throughput paradigm to natural compounds has the potential to increase their contribution for the pharmaceutical industry.
dc.description.peerreviewedYes
dc.description.publicationstatusYes
dc.languageEnglish
dc.language.isoeng
dc.publisherProus Science
dc.publisher.placeSpain
dc.publisher.urihttp://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_JournalId=2&p_RefId=1940442&p_IsPs=N
dc.relation.ispartofstudentpublicationN
dc.relation.ispartofpagefrom245
dc.relation.ispartofpageto256
dc.relation.ispartofissue4
dc.relation.ispartofjournalDrugs of the Future
dc.relation.ispartofvolume38
dc.rights.retentionY
dc.subject.fieldofresearchBiologically Active Molecules
dc.subject.fieldofresearchPharmacology and Pharmaceutical Sciences
dc.subject.fieldofresearchcode030401
dc.subject.fieldofresearchcode1115
dc.titleDiscovery and development of natural compounds into medicinal products
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.date.issued2013
gro.hasfulltextNo Full Text
gro.griffith.authorCamp, David B.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record